ATLANTA, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced that its founder and executive chairman, Jeff Arnold, and incoming chief executive officer, Brent Layton, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 10, 2024 at 8:15 a.m. PST.
A live audio webcast and replay of the event will be available online for a period of 30 days at https://investors.sharecare.com/news-and-events/events-and-presentations.
About Sharecare
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.
Media Relations:
Jen Martin Hall
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Relations:
Darrell Thomas
This email address is being protected from spambots. You need JavaScript enabled to view it.

| Last Trade: | US$1.43 |
| Daily Volume: | 0 |
| Market Cap: | US$531.790M |
September 10, 2024 August 09, 2024 March 28, 2024 | |

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load